Operating Expenses Summary of Roche Holding AG

Roche Holding AG's latest annual operating expenses in 2023 was 28.68 Billion CHF , up 12.91% from previous year.
Roche Holding AG's latest quarterly operating expenses in 2024 Q2 was 7.1 Billion CHF , down 0.0% from previous quarter.
Roche Holding AG reported a annual operating expenses of 25.4 Billion CHF in annual operating expenses 2022, up 1.64% from previous year.
Roche Holding AG reported a annual operating expenses of 24.99 Billion CHF in annual operating expenses 2021, up 5.91% from previous year.
Roche Holding AG reported a quarterly operating expenses of 7.1 Billion CHF for 2024 Q1, down -48.37% from previous quarter.
Roche Holding AG reported a quarterly operating expenses of 28.68 Billion CHF for 2023 FY, up 12.91% from previous quarter.

Annual Operating Expenses Chart of Roche Holding AG (2023 - 1998)

Historical Annual Operating Expenses of Roche Holding AG (2023 - 1998)

Year	Operating Expenses	Operating Expenses Growth
2023	28.68 Billion CHF	12.91%
2022	25.4 Billion CHF	1.64%
2021	24.99 Billion CHF	5.91%
2020	23.6 Billion CHF	-7.68%
2019	25.56 Billion CHF	2.95%
2018	24.83 Billion CHF	12.28%
2017	22.11 Billion CHF	8.81%
2016	20.32 Billion CHF	7.76%
2015	18.86 Billion CHF	-5.64%
2014	19.99 Billion CHF	8.32%
2013	18.45 Billion CHF	-3.93%
2012	19.21 Billion CHF	12.02%
2011	17.15 Billion CHF	-17.21%
2010	20.71 Billion CHF	6.53%
2009	19.44 Billion CHF	7.67%
2008	18.06 Billion CHF	0.77%
2007	17.92 Billion CHF	-9.07%
2006	19.71 Billion CHF	12.38%
2005	17.53 Billion CHF	16.05%
2004	15.11 Billion CHF	-12.71%
2003	17.31 Billion CHF	-13.25%
2002	19.95 Billion CHF	13.55%
2001	17.57 Billion CHF	42.0%
2000	12.37 Billion CHF	0.86%
1999	12.27 Billion CHF	-0.95%
1998	12.39 Billion CHF	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	7.1 Billion CHF	0.0%
2024 Q1	7.1 Billion CHF	-48.37%
2023 FY	28.68 Billion CHF	12.91%
2023 Q3	8.32 Billion CHF	-34.89%
2023 Q4	13.76 Billion CHF	65.37%
2023 Q2	12.78 Billion CHF	89.62%
2023 Q1	6.74 Billion CHF	-51.83%
2022 FY	25.4 Billion CHF	1.64%
2022 Q4	13.99 Billion CHF	59.35%
2022 Q1	6.7 Billion CHF	-50.56%
2022 Q2	12.27 Billion CHF	82.98%
2022 Q3	8.78 Billion CHF	-28.45%
2021 Q1	6.5 Billion CHF	-48.78%
2021 FY	24.99 Billion CHF	5.91%
2021 Q3	7.86 Billion CHF	-35.77%
2021 Q4	13.56 Billion CHF	72.48%
2021 Q2	12.24 Billion CHF	88.17%
2020 FY	23.6 Billion CHF	-7.68%
2020 Q1	6.12 Billion CHF	-54.18%
2020 Q2	11.53 Billion CHF	88.31%
2020 Q3	6.92 Billion CHF	-39.98%
2020 Q4	12.7 Billion CHF	83.55%
2019 Q4	13.36 Billion CHF	61.24%
2019 Q1	6.32 Billion CHF	-22.63%
2019 Q2	6.32 Billion CHF	0.0%
2019 FY	25.56 Billion CHF	2.95%
2019 Q3	8.29 Billion CHF	31.08%
2018 Q1	5.95 Billion CHF	-20.27%
2018 FY	24.83 Billion CHF	12.28%
2018 Q4	8.17 Billion CHF	0.0%
2018 Q3	8.17 Billion CHF	37.36%
2018 Q2	5.95 Billion CHF	0.0%
2017 Q2	6.05 Billion CHF	0.0%
2017 Q1	6.05 Billion CHF	-6.76%
2017 FY	22.11 Billion CHF	8.81%
2017 Q4	7.46 Billion CHF	0.0%
2017 Q3	7.46 Billion CHF	23.27%
2016 Q1	5.43 Billion CHF	-15.98%
2016 FY	20.32 Billion CHF	7.76%
2016 Q2	5.43 Billion CHF	0.0%
2016 Q4	6.49 Billion CHF	0.0%
2016 Q3	6.49 Billion CHF	19.43%
2015 FY	18.86 Billion CHF	-5.64%
2015 Q1	5.18 Billion CHF	-20.84%
2015 Q4	6.47 Billion CHF	0.0%
2015 Q3	6.47 Billion CHF	24.9%
2015 Q2	5.18 Billion CHF	0.0%
2014 Q3	6.54 Billion CHF	26.27%
2014 FY	19.99 Billion CHF	8.32%
2014 Q4	6.54 Billion CHF	0.0%
2014 Q2	5.18 Billion CHF	0.0%
2014 Q1	5.18 Billion CHF	-2.67%
2013 FY	18.45 Billion CHF	-3.93%
2013 Q2	4.92 Billion CHF	0.0%
2013 Q3	5.32 Billion CHF	8.21%
2013 Q4	5.32 Billion CHF	0.0%
2013 Q1	4.92 Billion CHF	0.0%
2012 FY	19.21 Billion CHF	12.02%
2011 FY	17.15 Billion CHF	-17.21%
2010 FY	20.71 Billion CHF	6.53%
2009 FY	19.44 Billion CHF	7.67%
2008 FY	18.06 Billion CHF	0.77%
2007 FY	17.92 Billion CHF	-9.07%
2006 FY	19.71 Billion CHF	12.38%
2005 FY	17.53 Billion CHF	16.05%
2004 FY	15.11 Billion CHF	-12.71%
2003 FY	17.31 Billion CHF	-13.25%
2002 FY	19.95 Billion CHF	13.55%
2001 FY	17.57 Billion CHF	42.0%
2000 FY	12.37 Billion CHF	0.86%
1999 FY	12.27 Billion CHF	-0.95%
1998 FY	12.39 Billion CHF	0.0%

Peer Operating Expenses Comparison of Roche Holding AG

Name	Operating Expenses	Operating Expenses Difference
AstraZeneca PLC	29.57 Billion USD	3.006%
Bristol-Myers Squibb Company PFD CONV 2	17.07 Billion USD	-68.057%
CSPC Pharmaceutical Group Limited	2.14 Billion USD	-1236.26%
Clarus Therapeutics Holdings, Inc.	50.96 Million USD	-56187.155%
Novartis AG	24.87 Billion USD	-15.351%
PT Kalbe Farma Tbk.	11823.24 Billion USD	99.757%

Global Stocks Search

Roche Holding AG (RHHBF)

Operating Expenses Summary of Roche Holding AG

Annual Operating Expenses Chart of Roche Holding AG (2023 - 1998)

Historical Annual Operating Expenses of Roche Holding AG (2023 - 1998)

Peer Operating Expenses Comparison of Roche Holding AG